Multi-drug resistance gene-1 (MDR1) is the crux in addressing drug resistance in many malignant tumors, and its encoded P-pg (P-glycoprotein) is able to pump intracellular drugs out of the cytoplasm by hydrolyzing ATP for its own energy supply [42]. The gene discussed is SRGN; the disease is cancer.